載入...
Nivolumab-Induced Autoimmune-Like Cholestatic Hepatitis in a Liver Transplant Recipient
Cancer treatment has taken giant strides in recent years with the advent of immunotherapy, including checkpoint inhibitors. The use of these medications in liver transplant recipients has been debated, and the added effect of previous hepatitis C infection on the immune system in this setting, is po...
Na minha lista:
| 發表在: | ACG Case Rep J |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wolters Kluwer
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7363460/ https://ncbi.nlm.nih.gov/pubmed/32766358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/crj.0000000000000416 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|